EastWest Bioscience Inc.
HBOSF
OTC PK
| 04/30/2022 | 01/31/2022 | 10/31/2021 | 07/31/2021 | 04/30/2021 | |
|---|---|---|---|---|---|
| Revenue | 62.00K | 90.30K | 70.90K | 7.70K | 165.10K |
| Total Other Revenue | 140.80K | 95.60K | 67.00K | 72.80K | 81.90K |
| Total Revenue | 202.90K | 185.80K | 137.90K | 80.50K | 247.00K |
| Cost of Revenue | 41.00K | 65.30K | 50.80K | 77.50K | 87.80K |
| Gross Profit | 161.90K | 120.60K | 87.10K | 3.00K | 159.20K |
| SG&A Expenses | 282.60K | 556.00K | 468.00K | 880.20K | 302.00K |
| Depreciation & Amortization | 19.70K | 19.70K | 19.90K | 24.40K | 24.30K |
| Other Operating Expenses | -- | 20.90K | 5.00K | -19.10K | -- |
| Total Operating Expenses | 343.20K | 662.70K | 546.80K | 970.40K | 414.10K |
| Operating Income | -140.30K | -476.80K | -408.90K | -889.90K | -167.10K |
| Income Before Tax | -442.80K | 1.65M | -454.80K | -778.20K | -120.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -442.80K | 1.65M | -454.80K | -778.20K | -120.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 69.00K | 18.20K | -- |
| Net Income | -442.80K | 1.65M | -385.90K | -760.00K | -120.60K |
| EBIT | -140.30K | -476.80K | -408.90K | -889.90K | -167.10K |
| EBITDA | -120.60K | -457.10K | -389.00K | -865.50K | -142.80K |
| EPS Basic | 0.00 | 0.02 | 0.00 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | -0.01 | 0.00 | -0.01 | 0.00 |
| EPS Diluted | 0.00 | 0.02 | 0.00 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | -0.01 | 0.00 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 100.66M | 99.86M | 97.57M | 97.62M | 94.74M |
| Average Diluted Shares Outstanding | 100.66M | 99.86M | 97.57M | 97.62M | 94.74M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
